1 312-422-1111
ibioadmin@ibio.org

Blog

IL ­ HB53 DRUG MANUFACTURER­ DISCLOSURES – OPPOSE

Requires manufacturers of brand name or generic prescription drugs to notify State purchasers, health insurers, health care service plan providers, pharmacy benefit managers, and the General Assembly of specified increases in drug prices at least 60 days before such increase and the cost of specified new prescription drugs within 3 days after approval by the U.S. Food and Drug Administration

Last Action: Assigned to Prescription Drug Affordability & Accessibility Committee (January 29, 2019)Primary Sponsor: Representative Mary E. Flowers (D)

Track Bill